Veterinary vaccines aim to improve the health and welfare of livestock, increase livestock production in a cost-effective way and prevent animal-to-human transmission of rabies in domestic and wild animals. Among the second generation animal vaccines, different vaccine types can be distinguished, depending on the characteristics of the rabies virus strain used and the cell substrate selected for virus replication, whether the vaccine is a live or inactivated vaccine. Recently, using recombinant genetic techniques, third generation live rabies vaccines for animals have been developed. Depending on the expression system, these vaccines are administered parenterally or orally. Oral rabies vaccines are commonly used in Europe for foxes and in the United States for raccoons.